General Inquiries

Head Office

Ambrilia Biopharma Inc.
1000 chemin du Golf
Verdun, Quebec, H3E 1H4
Tel.: (514) 751-2003
Fax: (514) 751-2502

French Subsidiary

Ambrilia Biopharma France S.A.
16 rue de la Banque
Paris, France 75002
Tel.: 33 1 40 20 72 72
Fax: 33 1 40 20 72 70

Investor Inquiries and Investor Kit Requests

Julie M. Thibodeau, B.Sc., MBA
Director, Communications
Tel.: (514) 751-2003 ext. 235
E-mail : jthibodeau@ambrilia.com or ir@ambrilia.com

Only public information or information which could otherwise be disclosed in accordance with Ambrilia’s Corporate Communication and Disclosure Policy shall be utilized in responding to electronic inquiries. Therefore, please provide your telephone number so that we may reach you.

Business Development and Licensing Opportunities

Daniel Böck, Ph.D.
Vice-President, Business Development and Licensing
Tel.: (514) 751-2003 ext. 236
E-mail: dbock@ambrilia.com

Clinical Trials Information

Dr. Raphaël Naudin
Senior Director, Clinical Research
Tel.: 33 1 40 20 72 72
E-mail: rnaudin@ambrilia.com

Careers

E-mail: careers@ambrilia.com

Mail to: Ambrilia Biopharma Inc.
1000 chemin du Golf
Verdun, Quebec
H3E 1H4
Fax: (514) 751-2502